{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:25:59Z","timestamp":1777861559030,"version":"3.51.4"},"reference-count":117,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2025AFB225"],"award-info":[{"award-number":["2025AFB225"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic, immune-mediated disorder characterized by relapsing inflammation of the gastrointestinal tract. Over the past decades, both the prevalence of IBD and the rates of obesity have increased globally, highlighting the potential impact of obesity on IBD pathogenesis and progression. Obesity is associated with a state of chronic low-grade inflammation, metabolic dysregulation, and altered gut microbiota, all of which may influence the onset, severity, and prognosis of IBD. However, existing evidence on the relationship between obesity and IBD remains limited and sometimes contradictory, with heterogeneity in study populations, obesity definitions, and outcome measures contributing to inconsistent findings. In this review, we summarize the epidemiology of obesity among IBD patients, explore the shared mechanisms linking obesity and IBD, discuss the influence of obesity on disease course, and evaluate the effects of currently available weight management interventions. This comprehensive overview aims to provide a clearer understanding of the complex interplay between obesity and IBD and to inform clinical management strategies.<\/jats:p>","DOI":"10.3390\/ijms27093911","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:33:37Z","timestamp":1777376017000},"page":"3911","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesity: An Overlooked Factor in Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"27","author":[{"given":"Jiao","family":"Xie","sequence":"first","affiliation":[{"name":"Health Management Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ling","sequence":"additional","affiliation":[{"name":"Health Management Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-4385","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[{"name":"Health Management Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, June 29). Available online: https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/3420#."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990\u20132021","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102848","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: An analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of Inflammatory Bowel Diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.dld.2023.04.003","article-title":"The global, regional, and national burden of inflammatory bowel diseases, 1990\u20132019: A systematic analysis for the global burden of disease study 2019","volume":"55","author":"Park","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MOG.0000000000000850","article-title":"Diet as a treatment for inflammatory bowel disease: Is it ready for prime time?","volume":"38","author":"Cusimano","year":"2022","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gutjnl-2012-303954","article-title":"Advances in inflammatory bowel disease pathogenesis: Linking host genetics and the microbiome","volume":"62","author":"Knights","year":"2013","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/gutjnl-2017-315866","article-title":"Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases","volume":"67","author":"Levine","year":"2018","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.14309\/ajg.0000000000001855","article-title":"Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study","volume":"117","author":"Gu","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/ibd\/izae165","article-title":"Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children with IBD","volume":"31","author":"Sila","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12014-023-09396-y","article-title":"Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight\/obesity on IBD: A pilot investigation","volume":"20","author":"Yan","year":"2023","journal-title":"Clin. Proteom."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kaazan, P., Seow, W., Yong, S., Heilbronn, L.K., and Segal, J.P. (2023). The Impact of Obesity on Inflammatory Bowel Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123256"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","article-title":"Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease","volume":"60","author":"Flores","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_16","first-page":"2304","article-title":"Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn\u2019s Disease","volume":"21","author":"Pringle","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00384-014-2051-3","article-title":"The effect of body weight on the severity and clinical course of ulcerative colitis","volume":"30","author":"Leifeld","year":"2015","journal-title":"Int. J. Color. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"otad007","DOI":"10.1093\/crocol\/otad007","article-title":"High Burden of Obesity and Low Rates of Weight Loss Pharmacotherapy in Inflammatory Bowel Disease: 10-Year Trend","volume":"5","author":"Elangovan","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ecco-jcc\/jjab097","article-title":"Prevalence and Impact of Obesity on Disease-specific Outcomes in a Population-based Cohort of Patients with Ulcerative Colitis","volume":"15","author":"Johnson","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10151-019-02080-0","article-title":"Outcomes of inflammatory bowel disease surgery in obese versus non-obese patients: A meta-analysis","volume":"23","author":"Hicks","year":"2019","journal-title":"Tech. Coloproctol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/ecco-jcc\/jjab088","article-title":"Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden","volume":"15","author":"Weissman","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/00365521.2024.2353099","article-title":"The relationship between weight change and inflammatory bowel disease. A population-based cohort study, the HUNT study","volume":"59","author":"Campo","year":"2024","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ueg2.12468","article-title":"Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: A population-based cohort study","volume":"11","author":"He","year":"2023","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41395-018-0031-x","article-title":"Childhood body mass index and risk of inflammatory bowel disease in adulthood: A population-based cohort study","volume":"113","author":"Jensen","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/CS20200895","article-title":"The complex role of adipokines in obesity, inflammation, and autoimmunity","volume":"135","author":"Taylor","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e70080","DOI":"10.1002\/iid3.70080","article-title":"Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis","volume":"13","author":"Corrado","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"802078","DOI":"10.1155\/2010\/802078","article-title":"The role of adipose tissue and adipokines in obesity-related inflammatory diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bilski, J., Mazur-Bialy, A., Wojcik, D., Surmiak, M., Magierowski, M., Sliwowski, Z., Pajdo, R., Kwiecien, S., Danielak, A., and Ptak-Belowska, A. (2019). Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. Biomolecules, 9.","DOI":"10.3390\/biom9120780"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nut.2011.09.009","article-title":"Visceral fat and gut inflammation","volume":"28","author":"Drouet","year":"2012","journal-title":"Nutrition"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/gutjnl-2011-300391","article-title":"Visceral adipocytes: Old actors in obesity and new protagonists in Crohn\u2019s disease?","volume":"61","author":"Zulian","year":"2012","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in Leanness and Obesity: JACC State-of-the-Art Review","volume":"77","author":"Perakakis","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"Educational, Clinical Practice Committee ESoP, Enteral N: ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejcn.1601412","article-title":"Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer","volume":"56","author":"Bauer","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_36","first-page":"130","article-title":"Circulating leptin levels in the assessment of Crohn\u2019s disease activity and its relation to nutritional status","volume":"41","author":"Zheng","year":"2024","journal-title":"Nutr. Hosp."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Kim, H., Nam, S., Chu, J.R., Kim, J.H., Lim, J.S., Kim, S.E., and Sung, M.K. (2022). Protective Effects of High-Fat Diet against Murine Colitis in Association with Leptin Signaling and Gut Microbiome. Life, 12.","DOI":"10.3390\/life12070972"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12944-020-01404-6","article-title":"Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines","volume":"19","author":"Gholamrezayi","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_40","first-page":"275","article-title":"Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease","volume":"71","author":"Karaskova","year":"2022","journal-title":"Physiol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13679-023-00506-3","article-title":"GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: From Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use","volume":"12","author":"Arvanitakis","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.matbio.2024.08.007","article-title":"Hyperglycemic environments directly compromise intestinal epithelial barrier function in an organoid model and hyaluronan (approximately 35 kDa) protects via a layilin dependent mechanism","volume":"133","author":"Jatana","year":"2024","journal-title":"Matrix Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ibd\/izac120","article-title":"Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn\u2019s Disease: A Review of the Literature","volume":"29","author":"Gu","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Eder, P., Adler, M., Dobrowolska, A., Kamhieh-Milz, J., and Witowski, J. (2019). The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells, 8.","DOI":"10.3390\/cells8060628"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Karaskova, E., Velganova-Veghova, M., Geryk, M., Foltenova, H., Kucerova, V., and Karasek, D. (2021). Role of Adipose Tissue in Inflammatory Bowel Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084226"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gutjnl-2011-300370","article-title":"Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn\u2019s disease","volume":"61","author":"Gonzalez","year":"2012","journal-title":"Gut"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Balint, A., Farkas, K., Mehi, O., Kintses, B., Vasarhelyi, B.M., Ari, E., Pal, C., Madacsy, T., Maleth, J., and Szanto, K.J. (2020). Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome. Pharmaceuticals, 13.","DOI":"10.3390\/ph13110346"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/s41467-020-17840-y","article-title":"Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bacsur, P., Resal, T., Farkas, B., Jojart, B., Gyuris, Z., Jaksa, G., Pinter, L., Takacs, B., Pal, S., and Gacser, A. (2024). Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn\u2019s Disease. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092100"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Islam, M.R., Arthur, S., Haynes, J., Butts, M.R., Nepal, N., and Sundaram, U. (2022). The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders. Nutrients, 14.","DOI":"10.3390\/nu14030624"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rodrigues, V.F., Elias-Oliveira, J., Pereira, I.S., Pereira, J.A., Barbosa, S.C., Machado, M.S.G., and Carlos, D. (2022). Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.934695"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ashrafian, F., Shahriary, A., Behrouzi, A., Moradi, H.R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., and Khatami, S. (2019). Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02155"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wang, J., Chen, W.D., and Wang, Y.D. (2020). The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01065"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ibd\/izad111","article-title":"Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not","volume":"30","author":"Sehgal","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/2050640620954556","article-title":"Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort","volume":"8","author":"Greuter","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/apt.18513","article-title":"Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S","volume":"61","author":"Desai","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/MIB.0000000000000560","article-title":"Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease","volume":"21","author":"Seminerio","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/MIB.0000000000001128","article-title":"Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery","volume":"23","author":"Adams","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00384-021-03968-w","article-title":"Visceral adiposity and inflammatory bowel disease","volume":"36","author":"Rowan","year":"2021","journal-title":"Int. J. Color. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/apt.14018","article-title":"Visceral adiposity predicts post-operative Crohn\u2019s disease recurrence","volume":"45","author":"Holt","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ibd\/izy278","article-title":"Visceral Adipose Tissue Is Associated With Stricturing Crohn\u2019s Disease Behavior, Fecal Calprotectin, and Quality of Life","volume":"25","author":"Bryant","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40259-022-00522-0","article-title":"Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases","volume":"36","author":"Bassi","year":"2022","journal-title":"BioDrugs"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Tang, C., Wang, X., Qin, L.Q., and Dong, J.Y. (2021). Mediterranean Diet and Mortality in People with Cardiovascular Disease: A Meta-Analysis of Prospective Cohort Studies. Nutrients, 13.","DOI":"10.3390\/nu13082623"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/j.gastro.2014.12.035","article-title":"Nutrients, foods, and colorectal cancer prevention","volume":"148","author":"Song","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"Pellegrini","year":"2016","journal-title":"Gut"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1479-7364-7-24","article-title":"Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn\u2019s disease patients","volume":"7","author":"Marlow","year":"2013","journal-title":"Hum. Genom."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e13369","DOI":"10.1111\/jfbc.13369","article-title":"The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions","volume":"44","author":"Arya","year":"2020","journal-title":"J. Food Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Li, L., Peng, P., Ding, N., Jia, W., Huang, C., and Tang, Y. (2023). Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?. Antioxidants, 12.","DOI":"10.3390\/antiox12040967"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Parada Venegas, D., De la Fuente, M.K., Landskron, G., Gonzalez, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01486"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11807","DOI":"10.1038\/s41598-018-29992-5","article-title":"Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer","volume":"8","author":"Chiu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izaa097","article-title":"Multidimensional Impact of Mediterranean Diet on IBD Patients","volume":"27","author":"Chicco","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Strauss, J.C., Haskey, N., Ramay, H.R., Ghosh, T.S., Taylor, L.M., Yousuf, M., Ohland, C., McCoy, K.D., Ingram, R.J.M., and Ghosh, S. (2023). Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087323"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/ajg.2017.371","article-title":"Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance","volume":"112","author":"Baratta","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Garcia-Mateo, S., Martinez-Dominguez, S.J., Gargallo-Puyuelo, C.J., Arroyo Villarino, M.T., Laredo De La Torre, V., Gallego, B., Alfambra, E., and Gomollon, F. (2023). Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease. Nutrients, 15.","DOI":"10.3390\/nu15183983"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41392-021-00549-9","article-title":"Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome","volume":"6","author":"Kong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Luiskari, L., Linden, J., Lehto, M., Salmenkari, H., and Korpela, R. (2024). Ketogenic Diet Protects from Experimental Colitis in a Mouse Model Regardless of Dietary Fat Source. Nutrients, 16.","DOI":"10.3390\/nu16091348"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1239025","DOI":"10.3389\/fphar.2023.1239025","article-title":"Unveiling the therapeutic potential of exogenous beta-hydroxybutyrate for chronic colitis in rats: Novel insights on autophagy, apoptosis, and pyroptosis","volume":"14","author":"Abdelhady","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"109736","DOI":"10.1016\/j.jnutbio.2024.109736","article-title":"The beneficial impact of ketogenic diets on chemically-induced colitis in mice depends on the diet\u2019s lipid composition","volume":"134","author":"Hadzic","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/DMSO.S456571","article-title":"Effects of Different Carbohydrate Content Diet on Gut Microbiota and Aortic Calcification in Diabetic Mice","volume":"17","author":"Shen","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1039\/D1FO02288A","article-title":"Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14309\/ajg.0000000000002040","article-title":"Working to Answer the Effectiveness of Nutrition in IBD: Still a Ways to Go","volume":"118","author":"Otley","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yan, J., Wang, L., Gu, Y., Hou, H., Liu, T., Ding, Y., and Cao, H. (2022). Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges. Nutrients, 14.","DOI":"10.3390\/nu14194003"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s10620-016-4307-y","article-title":"Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease","volume":"61","author":"Suskind","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Suskind, D.L., Lee, D., Kim, Y.M., Wahbeh, G., Singh, N., Braly, K., Nuding, M., Nicora, C.D., Purvine, S.O., and Lipton, M.S. (2020). The Specific Carbohydrate Diet and Diet Modification as Induction Therapy for Pediatric Crohn\u2019s Disease: A Randomized Diet Controlled Trial. Nutrients, 12.","DOI":"10.3390\/nu12123749"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MPG.0000000000001619","article-title":"Lack of Mucosal Healing From Modified Specific Carbohydrate Diet in Pediatric Patients with Crohn Disease","volume":"65","author":"Wahbeh","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3748\/wjg.v22.i6.2111","article-title":"Response to strict and liberalized specific carbohydrate diet in pediatric Crohn\u2019s disease","volume":"22","author":"Burgis","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MPG.0000000000000449","article-title":"Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease","volume":"59","author":"Cohen","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1111\/jocn.17186","article-title":"Experience of diet in patients with inflammatory bowel disease: A thematic synthesis of qualitative studies","volume":"33","author":"Xiong","year":"2024","journal-title":"J. Clin. Nurs."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lamers, C.R., de Roos, N.M., and Witteman, B.J.M. (2020). The association between inflammatory potential of diet and disease activity: Results from a cross-sectional study in patients with inflammatory bowel disease. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01435-4"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Panufnik, P., Wiecek, M., Kaniewska, M., Lewandowski, K., Szwarc, P., and Rydzewska, G. (2022). Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease. Nutrients, 14.","DOI":"10.3390\/nu14234965"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.15403\/jgld-5482","article-title":"Diet Optimization in Inflammatory Bowel Disease: Impact on Disease Relapse and Inflammatory Markers. A 1-year Prospective Trial","volume":"33","author":"Preda","year":"2024","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Yan, D., Ye, S., He, Y., Wang, S., Xiao, Y., Xiang, X., Deng, M., Luo, W., Chen, X., and Wang, X. (2023). Fatty acids and lipid mediators in inflammatory bowel disease: From mechanism to treatment. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1286667"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"106074","DOI":"10.1016\/j.fitote.2024.106074","article-title":"Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects","volume":"177","author":"Zhang","year":"2024","journal-title":"Fitoterapia"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jhn.12530","article-title":"The low FODMAP diet in the management of irritable bowel syndrome: An evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice","volume":"31","author":"Whelan","year":"2018","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","article-title":"Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial","volume":"158","author":"Cox","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3748\/wjg.v30.i34.3868","article-title":"Examining dietary interventions in Crohn\u2019s disease","volume":"30","author":"Chen","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Wiecek, M., Panufnik, P., Kaniewska, M., Lewandowski, K., and Rydzewska, G. (2022). Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD. Nutrients, 14.","DOI":"10.3390\/nu14214562"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.clnu.2022.11.001","article-title":"Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial","volume":"41","author":"Algera","year":"2022","journal-title":"Clin. Nutr."},{"key":"ref_104","first-page":"e56579","article-title":"A Review of the Efficacy of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Managing Gastrointestinal Symptoms Related to Cancer Treatment","volume":"16","author":"Almasaudi","year":"2024","journal-title":"Cureus"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/gutjnl-2014-307264","article-title":"Diets that differ in their FODMAP content alter the colonic luminal microenvironment","volume":"64","author":"Halmos","year":"2015","journal-title":"Gut"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","article-title":"Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease","volume":"23","author":"Pedersen","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3748\/wjg.v29.i12.1779","article-title":"Obesity and novel management of inflammatory bowel disease","volume":"29","author":"Kim","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ibd\/izae250","article-title":"GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD","volume":"31","author":"Levine","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_110","first-page":"478","article-title":"Effectiveness and safety of a GLP-1 agonist in obese patients with inflammatory bowel disease","volume":"116","author":"Menchen","year":"2024","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1007\/s10620-024-08720-2","article-title":"Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease","volume":"69","author":"Klein","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.18138","article-title":"Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease","volume":"60","author":"Desai","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.13784","article-title":"GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells","volume":"172","author":"Sun","year":"2024","journal-title":"Immunology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/ans.13585","article-title":"Outcome of three common bariatric procedures in the public sector","volume":"87","author":"Clough","year":"2017","journal-title":"ANZ J. Surg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11695-015-1657-z","article-title":"Bariatric Surgery Worldwide 2013","volume":"25","author":"Angrisani","year":"2015","journal-title":"Obes. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.surge.2022.04.008","article-title":"Systematic review: Outcomes of bariatric surgery in patients with inflammatory bowel disease and de-novo IBD development after bariatric surgery","volume":"21","author":"Mian","year":"2023","journal-title":"Surgeon"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1007\/s11695-022-06226-2","article-title":"De Novo Inflammatory Bowel Disease Following Bariatric Surgery: A Systematic Review and Meta-analysis","volume":"32","author":"Kermansaravi","year":"2022","journal-title":"Obes. Surg."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:27:23Z","timestamp":1777523243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":117,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27093911"],"URL":"https:\/\/doi.org\/10.3390\/ijms27093911","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}